Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning^*

References

• Zakharov S, Kotikova K, Nurieva O, et al. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol. 2017;55:249–259.
   PubMed Web of Science ®Google Scholar
• Zhang G, Grews K, Wiseman H, et al. Application to Include Fomepizole on the WHO Model List of Essential Medicines. Journal [serial on the Internet]. 2012; 2015. Available from: http://www.who.int/selection_medicines/committees/expert/19/applications/Fomepizole_4_2_AC_Ad.pdf.
   Google Scholar
• Bezdicek O, Michalec J, Vaneckova M, et al. Cognitive sequelae of methanol poisoning involve executive dysfunction and memory impairment in cross-sectional and long-term perspective. Alcohol. 2017;59:27–35.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Diblik P, et al. Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. Clin Toxicol. 2015;53:884–892.
   PubMed Web of Science ®Google Scholar
• Hovda KE, Hunderi OH, Tafjord AB, et al. Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs. J Intern Med. 2005;258:181–190.
   PubMed Web of Science ®Google Scholar
• Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415–446.
   PubMed Web of Science ®Google Scholar
• Liesivuori J, Savolainen H. Methanol and formic acid toxicity: biochemical mechanisms. Pharmacol Toxicol. 1991;69:157–163.
   PubMedGoogle Scholar
• Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986;1:309–334.
   PubMedGoogle Scholar
• Karayel F, Turan AA, Sav A, et al. Methanol intoxication pathological changes of central nervous system (17 Cases). Am J Forensic Med Pathol. 2010;31:34–36.
   PubMed Web of Science ®Google Scholar
• Vaneckova M, Zakharov S, Klempir J, et al. Imaging findings after methanol intoxication (cohort of 46 patients). Neuro Endocrinol Lett. 2016;36:737–744.
   Web of Science ®Google Scholar
• Zakharov S, Kotikova K, Vaneckova M, et al. Acute methanol poisoning: prevalence and predisposing factors of haemorrhagic and non-haemorrhagic brain lesions. Basic Clin Pharmacol Toxicol. 2016;119:228–238.
   PubMed Web of Science ®Google Scholar
• Sharpe JA, Hostovsky M, Bilbao JM, et al. Methanol optic neuropathy: a histopathological study. Neurology. 1982;32:1093–1100.
   PubMed Web of Science ®Google Scholar
• Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53–89.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787–795.
   PubMed Web of Science ®Google Scholar
• Calabrese V, Butterfield DA, Scapagnini G, et al. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal. 2006;8:444–477.
   PubMed Web of Science ®Google Scholar
• Calabrese V, Colombrita C, Sultana R, et al. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid Redox. Signaling. 2006;8:404–416.
   Google Scholar
• Bell KF, Al-Mubarak B, Fowler JH, et al. Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA. 2011;108:E1–E2.
   PubMed Web of Science ®Google Scholar
• Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress? Med Gas Res. 2011;1:29.
   PubMedGoogle Scholar
• Halliwell B. Role of free radicals in the neurodegenerative diseases – therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685–716.
   PubMed Web of Science ®Google Scholar
• Halliwel B, Guttefridge JMC. Free radicals in biology and medicine. 4th ed. UK: Oxford: University press; 2007.
   Google Scholar
• Zhang RL, Brennan ML, Shen ZZ, et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem. 2002;277:46116–46122.
   PubMed Web of Science ®Google Scholar
• Plog BA, Dashnaw ML, Hitomi E, et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci. 2015;35:518–526.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Navratil T, et al. Fomepizole versus ethanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol. 2015;53:797–806.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Navratil T, et al. Acute methanol poisonings: folates administration and visual sequelae. J Appl Biomed. 2014;12:309–316.
   Web of Science ®Google Scholar
• Zakharov S, Navratil T, Salek T, et al. Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. Biomed Pap Med Fac Univer Palacky´. 2015;159:666–676.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Navratil T, et al. Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning. Kidney Int. 2014;86:199–207.
   PubMed Web of Science ®Google Scholar
• Rulisek J, Balik M, Polak F, et al. Cost-effectiveness of hospital treatment and outcomes of acute methanol poisoning during the Czech Republic mass poisoning outbreak. J Crit Care. 2017;39:190–198.
   PubMed Web of Science ®Google Scholar
• Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;3:CD003773.
   Google Scholar
• Zakharov S, Rulisek J, Nurieva O, et al. Intermittent versus continuous renal replacement therapy in acute methanol poisoning: comparison of clinical effectiveness in mass poisoning outbreaks. Ann Intensive Care. 2017;7:77.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Kotikova K, et al. Factors predicting optic nerve axonal degeneration after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:251–261.
   Web of Science ®Google Scholar
• Mcmartin KE, Makar AB, Martin G, et al. Methanol poisoning.1. Role of formic-acid in development of metabolic-acidosis in monkey and reversal by 4-methylpyrazole. Biochem Med. 1975;13:319–333.
   PubMed Web of Science ®Google Scholar
• Hubacek JA, Pelclova D, Seidl Z, et al. Rare alleles within the CYP2E1 (MEOS System) could be associated with better short-term health outcome after acute methanol poisoning. Basic Clin Pharmacol Toxicol. 2015;116:168–172.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Navratil T, Pelclova D. Analysis of serum anion gap and osmolal gap in diagnosis and prognosis of acute methanol poisoning: clinical study in 86 patients. Monatsh Chem. 2015;146:787–794.
   Web of Science ®Google Scholar
• Lock EA, Zhang J, Checkoway H. Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence. Toxicol Appl Pharmacol. 2013;266:345–355.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52:601–623.
   PubMed Web of Science ®Google Scholar
• Carini M, Aldini G, Facino RM. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom Rev. 2004;23:281–305.
   PubMed Web of Science ®Google Scholar
• Uchida K. Histidine and lysine as targets of oxidative modification. Amino Acids. 2003;25:249–257.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Miyake N, Hiai H, et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett. 1995;359:189–191.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81–128.
   PubMed Web of Science ®Google Scholar
• Li SY, Li Q, Shen JJ, et al. Attenuation of acetaldehyde-induced cell injury by overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role of MAP kinase signaling. J Mol Cell Cardiol. 2006;40:283–294.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JM. Free radicals in medicine and biology. Clarendon: Oxford; 1999.
   Google Scholar
• Rice-Evans C, Okunade G, Khan R. The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine. Free Radic Res Commun. 1989;7:45–54.
   PubMed Web of Science ®Google Scholar
• Polidori MC, Cherubini A, Stahl W, et al. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radical Res. 2002;36:265–268.
   PubMed Web of Science ®Google Scholar
• Gariballa SE, Hutchin TP, Sinclair AJ. Antioxidant capacity after acute ischaemic stroke. Qjm. 2002;95:685–690.
   PubMed Web of Science ®Google Scholar
• Riahi Y, Cohen G, Shamni O, et al. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol-Endocrinol Metab. 2010;299:E879–EE86.
   PubMed Web of Science ®Google Scholar
• Schneider C, Tallman KA, Porter NA, et al. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem. 2001;276:20831–20838.
   PubMed Web of Science ®Google Scholar
• Massey KA, Nicolaou A. Lipidomics of polyunsaturated-fatty-acid-derived oxygenated metabolites. Biochem Soc Trans. 2011;39:1240–1246.
   PubMed Web of Science ®Google Scholar
• Parthasarathy NJ, Kumar RS, Manikandan S, et al. Methanol-induced oxidative stress in rat lymphoid organs. J Occup Health. 2006;48:20–27.
   PubMed Web of Science ®Google Scholar
• Paasma R, Hovda KE, Hassanian-Moghaddam H, et al. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes–a multicenter study. Clin Toxicol. 2012;50:823–831.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Pelclova D, Urban P, et al. Use of out-of-hospital ethanol administration to improve outcome in mass methanol outbreaks. Ann Emerg Med. 2016;68:52–61.
   PubMed Web of Science ®Google Scholar
• Zakharov S, Nurieva O, Kotikova K, et al. Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning. Monatsh Chem. 2017;148:409–419.
   PubMed Web of Science ®Google Scholar
• Wang Q, Kalogeris TJ, Wang M, et al. Antecedent ethanol attenuates cerebral ischemia/reperfusion-induced leukocyte-endothelial adhesive interactions and delayed neuronal death: role of large conductance, Ca2þ-activated Kþ channels. Microcirculation. 2010;17:427–438.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun AY, Simonyi A, et al. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med. 2007;43:1048–1060.
   PubMed Web of Science ®Google Scholar
• Lovinger DM1, White G, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 1989;243:1721–1724.
   PubMed Web of Science ®Google Scholar
• Klistorner A, Arvind H, Garrick R, et al. Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis. Invest Ophthalmol Vis Sci. 2010;51:2770–2777.
   PubMed Web of Science ®Google Scholar
• Nurieva O, Kotikova K, Urban P, et al. Prevalence, dynamics, and biochemical predictors of optic nerve remyelination after methanol-induced acute optic neuropathy: a two-year prospective study in 54 patients. Monatsh Chem. 2016;147:239–249.
   Web of Science ®Google Scholar
• Johnson VE, Stewart JE, Begbie FD, et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136:28–42.
   PubMed Web of Science ®Google Scholar